No previous research has examined the association between metabolic syndrome (MetSyn) and health-related quality of life (HRQoL) using standard criteria for defining MetSyn. We hypothesized that MetSyn would be associated with lower HRQoL on measures of physical and mental health. Methods and Procedures: Participants were 361 individuals in two randomized weight loss trials. MetSyn was defined by the National Cholesterol Education Panel criteria. The Medical Outcomes Study, Short Form-36 (SF-36) was used to assess HRQoL. Differences in HRQoL and in clinical and psychosocial characteristics were compared among participants with and without MetSyn. Multiple regression was used to determine predictors of HRQoL. Results: MetSyn was associated with lower scores on the physical function and general health subscales of the SF-36 and on the physical component summary (PCS) score. This association remained after controlling for age or depression but was eliminated by controlling for BMI. MetSyn was not associated with lower mental quality of life, a higher depression score, tobacco or alcohol use, or a higher rate of psychosocial stressors. Discussion: Individuals with MetSyn reported lower HRQoL. This appeared to be an effect of increased weight, rather than a unique effect of MetSyn. Larger studies are needed to assess whether MetSyn may have an independent effect on HRQoL.
association between MetSyn and lower HRQoL could be explained, in part, by a higher BMI or by a higher rate of psy chosocial complications (e.g., depression, history of mental illness, alcohol and tobacco abuse, and stress) among those with the syndrome.
Methods And procedures participants
Participants were 404 overweight and obese individuals who took part in one of two randomized weight control trials that have been reported previously (14, 15) . Participants in both studies were required to have a BMI of 30-45 kg/m 2 and were excluded if they had signifi cant medical or psychiatric comorbidities, described previously (15) . These included uncontrolled hypertension (>140/90 mm Hg), types 1 or 2 diabetes, or the use of medications known to cause long-term changes in weight. The presence of MetSyn was assessed using the National Cholesterol Education Program criteria (4) . Participants who took medications for hypertension or hypercholesterolemia were counted as meeting the blood pressure and triglyceride criteria for metabolic syndrome.
outcomes measures . The SF-36 was used to assess HRQoL. This measure includes eight subscales, all of which are used to derive a summary measure of physical health and a summary measure of mental health (12, 13) . Higher scores, both on the eight subscales and the two summary mea sures, indicate better functioning.
Depression. Symptoms of depression were assessed using the Beck Depression Inventory (BDI-II), the standard measure for depression in mental health (16) . Scores range from 0 to 63, with higher values indic ative of greater symptoms of depression. Scores of 0-13 are considered minimal (i.e., in the normal range). Participants also reported whether they had a history of mental health problems, as assessed by the Weight and Lifestyle Inventory (17) .
Lifestyle habits. Lifestyle habits, including smoking and alcohol intake, were also assessed with the Weight and Lifestyle Inventory (17) . This questionnaire has good reliability for these items (18) . The Weight and Lifestyle Inventory was also used to identify ongoing sources of stress, including those related to work, intimate relation ships, and legal/financial troubles. Participants responded yes or no to the presence of each of eight psychosocial stressors, as described previously (17) .
statistical analysis
Full data concerning MetSyn and quality of life were available for 361 of the original 404 participants. Individuals who were not included in the analysis data set did not differ in age, weight, BMI, education, or ethnicity from the 361 persons for whom full data were available. If a participant had missing data on one or more components of MetSyn but met at least three criteria, the individual was designated as having the syndrome.
Differences in weight and in other characteristics between participants with and without MetSyn were compared using t-tests for continuous variables and chi-square tests for categorical variables. Similar analyses were used to compare individuals with and without MetSyn on: (i) the eight subscales of the SF-36; (ii) symptoms of depression; (iii) lifestyle habits; and (iv) psychosocial stressors.
Zero-order correlations were used to estimate the strength of asso ciation between HRQoL and single variables of interest. Multivariable regression was then used to assess the total variance in HRQoL explained by all predictor variables. All analyses were conducted using Stata soft ware, version 9.2 (Stata Corporation, College Station, TX). A P value <0.05 was considered significant for all analyses. 
Metabolic syndrome
Participants with MetSyn had a significantly greater age (P = 0.002), height (P < 0.001), weight (P < 0.001), and BMI (P < 0.001) than those without the syndrome ( Table 1) . A higher percentage of individuals with MetSyn were white (P = 0.02) and male (P < 0.001). As expected, participants with MetSyn also had significantly higher blood pressure, higher fasting glucose and insulin, higher triglycerides, and lower high-den sity lipoprotein cholesterol than did those without MetSyn (P < 0.001 for all comparisons). Low-density lipoprotein cholesterol levels did not differ significantly between the two groups ( Table 1) .
Quality of life
Comparisons of HRQoL between participants with and with out MetSyn are shown in Table 2 . Individuals with MetSyn had significantly lower scores on two of the eight subscales of the Insulin resistance was deter mined using the homeostasis model of insulin resistance (26) . Scores range fromSF-36. These were, physical functioning (P = 0.021) and gen-Depression Inventory scores or in the percentage of patients eral health (P = 0.007). Participants with MetSyn also scored who reported a history of mental health problems or of alco significantly lower on the physical component summary (PCS) hol or tobacco use. There also were no significant differences score (P = 0.013). No differences were observed between those between groups in the number of psychosocial stressors with and without MetSyn on any of the four subscales of the ( Table 3) . SF-36 that assessed dimensions of mental health or in the men tal component summary score ( Table 2) .
correlations and regression analyses
Correlation and regression analyses are shown in Tables 4   psychosocial status and lifestyle habits and 5 for the PCS score of the SF-36. In univariable analyThe psychosocial characteristics of participants with and ses, lower values on the PCS score were associated with the without MetSyn are shown in Table 3 . No significant dif-presence of MetSyn, higher BMI values and depression scores, ferences were observed between the two groups in Beck and with higher age. By contrast, there was no association between the PCS score and years of education, gender, ethnic- were entered into the regression according to the strength of their association-BMI, depression score, age, and MetSyn. As shown in Table 5 , three variables-BMI, depression score, and age-explained 15% of the variance in the PCS score. MetSyn did not contribute significantly to the variance explained after accounting for these three variables. Secondary analyses showed that the effect of MetSyn was eliminated by controlling for BMI alone ( Table 5) .
dIscussIon
This study found that MetSyn was associated with lower HRQoL on two of the physical subscales of the SF-36. These were physical function (i.e., limitations in daily activities due to physical health) and general health (i.e, self-reported over all health status). In addition, participants with MetSyn scored significantly lower on the PCS score than did persons with out the syndrome. By contrast, no association was observed between MetSyn and the mental component summary score or any of the SF-36 subscales related to mental health. There also was no association between MetSyn and symptoms of depres sion, alcohol or tobacco use, or psychosocial stressors.
Participants in the present study who had MetSyn had a significantly higher BMI than those without the syndrome (37.4 kg/m 2 vs. 34.7 kg/m 2 , respectively). Correlation analy ses showed that both BMI and MetSyn were associated with a lower PCS score. Results of multiple regression analysis, however, showed that MetSyn did not account for a signifi cant amount of the variance in PCS scores after controlling for BMI. Thus, the reduced HRQoL in participants with MetSyn appeared to be related to their greater BMI, rather than to MetSyn per se. Numerous studies have shown that a higher BMI is associated with lower HRQoL (19) (20) (21) (22) (23) (24) (25) .
Two previous studies reported that MetSyn was associated with reduced HRQoL (7, 9) . However, neither of these inves tigations controlled for the effect of BMI. In addition, neither of these studies used standardized criteria to define MetSyn, such as the criteria used by the National Cholesterol Education Panel (4) or World Health Organization (10, 11) . A third study found lower SF-36 scores at baseline for all eight domains among a population of surgically treated obese patients, but no association of lower quality of life with insulin resistance (19) . The other criteria for MetSyn were not examined.
The present study had several limitations. First, patients with type 2 diabetes were excluded from both of the clinical trials used for the analysis. Obese individuals with type 2 diabetes are likely to meet the criteria for MetSyn and may experience lower HRQoL than persons with the syndrome who do not have diabetes. Second, our sample consisted principally of persons from middle-to upper-middle socioeconomic backgrounds (mean education of 15.6 years in the present analysis). Higher socioeconomic status may protect obese individuals from the potential adverse health and psychosocial consequences of MetSyn. Third, we failed to observe the expected relationship between psychosocial stress and MetSyn. This may have been attributable to our use of a suboptimal measure to detect stress. Future studies should correct this limitation.
In summary, the present study found that excess weight appeared to explain the decrease in HRQoL observed in par ticipants with MetSyn. Larger studies of more diverse samples are needed to confirm this finding.
